Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 9OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

Capecitabine 8Fluorouracil 6Radiotherapy 5Leucovorin 5Oxaliplatin 4Laparoscopy 4XELOX 3Cetuximab 3Irinotecan 2Folfox protocol 2Drug Therapy 2Chemoradiotherapy 2selinexor 1citric acid, ispaghula husk, sodium bicarbonate drug combination 1capecitabine-irinotecan combination 1Vitamin D Response Element 1Vi-siblin 1Transanal Endoscopic Microsurgery 1Robotics 1Robotic Surgical Procedures 1Psyllium 1Polyethylene Glycols 1N-hydroxy-4-acetylaminostilbene 1Metronidazole 1Mastectomy, Segmental 1Liver Extracts 1Immunohistochemistry 1Frozen Sections 1Fluorescein Angiography 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Rectal Neoplasms × Mastectomy, Segmental × Clear all
NCT02490709 2015-07-07

Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy

National Cancer Center, Korea

Phase 2 Unknown
86 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡